Passage Bio, Inc.
PASG
$0.3905
$0.012.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.84% | 36.54% | 38.78% | 31.61% | 33.86% |
| Total Depreciation and Amortization | -30.23% | -17.20% | -17.90% | -12.09% | -5.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.18% | 20.45% | -45.10% | -15.42% | -20.94% |
| Change in Net Operating Assets | 70.07% | -175.33% | -131.81% | -219.56% | -162.89% |
| Cash from Operations | 42.64% | 38.73% | 28.68% | 18.69% | 22.09% |
| Capital Expenditure | 71.67% | 76.71% | 94.56% | 97.99% | 92.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.89% | -15.91% | -10.90% | 101.91% | 126.18% |
| Cash from Investing | 0.08% | -15.77% | -9.97% | 108.16% | 138.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.51% | 6,473.33% | 5,776.16% | 3,757.83% | 2,211.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.51% | 6,473.33% | 1,878.16% | 1,078.28% | 733.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 681.65% | 223.05% | 95.56% | 90.93% | 104.98% |